ePrint
Journal Title :   Current Pharmaceutical Biotechnology

Volume No :   2

Issue No :   4

Article Title :   Zevalin™: 90Yttrium Labeled Anti-CD20 (Ibritumomab Tiuxetan), a New Treatment for Non-Hodgkin ’ s Lymphoma

Page No :   341   To   349

Total Pages:   9

Article Details Section